| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1365-2516.2010.02459.X |
| P698 | PubMed publication ID | 21323797 |
| P2093 | author name string | G-S Zhang | |
| Y-Y Luo | |||
| P2860 | cites work | Differences between Type I Autoimmune Inhibitors of Fibrin Stabilization in Two Patients with Severe Hemorrhagic Disorder | Q30430667 |
| Contribution of fibrin stabilization to clot strength. Supplementation of factor XIII-deficient plasma with the purified zymogen | Q35206931 | ||
| Diagnostic and genetic studies on fibrin-stabilizing factor with a new assay based on amine incorporation | Q35570532 | ||
| Autoimmune antibody (IgG Kansas) against the fibrin stabilizing factor (factor XIII) system | Q37481090 | ||
| Congenital factor XIII deficiency caused by two mutations in eight Tunisian families: molecular confirmation of a founder effect | Q39190237 | ||
| Practolol therapy associated with a systemic lupus erythematosus-like syndrome and an inhibitor to factor XIII | Q41249098 | ||
| A reversed activity staining procedure for detection of an acquired antibody against factor XIII in a girl with factor XIII deficiency | Q43570820 | ||
| Extravascular fibrin formation and dissolution in synovial tissue of patients with osteoarthritis and rheumatoid arthritis | Q44487593 | ||
| Prophylactic and perioperative replacement therapy for acquired factor XIII deficiency | Q47613699 | ||
| Calcium-dependent unmasking of active center cysteine during activation of fibrin stabilizing factor. | Q47824183 | ||
| A New Haemorrhagic Disorder with Defective Fibrin Stabilization and Cryofibrinogenaemia | Q47850857 | ||
| Dissociation of the subunit structure of fibrin stabilizing factor during activation of the zymogen. | Q54325655 | ||
| Effects of crosslinking on the rigidity and proteolytic susceptibility of human fibrin clots | Q54498598 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 393-398 | |
| P577 | publication date | 2011-02-15 | |
| P1433 | published in | Haemophilia | Q15753375 |
| P1476 | title | Acquired factor XIII inhibitor: clinical features, treatment, fibrin structure and epitope determination | |
| P478 | volume | 17 |
| Q45877346 | A case of acquired FXIII deficiency with severe bleeding symptoms |
| Q38052068 | Acquired FXIII inhibitors: a systematic review |
| Q51285755 | Acquired Factor XIII inhibitor associated with mantle cell lymphoma. |
| Q93181359 | Acquired factor XIII deficiency: A review |
| Q45859173 | Acquired factor XIII deficiency: still a clinical challenge in the era of novel therapy |
| Q38038687 | Biology of Factor XIII and clinical manifestations of Factor XIII deficiency |
| Q45869518 | Development of anti-factor XIII antibodies in a patient with hereditary factor XIII deficiency receiving therapy for chronic hepatitis C. |
| Q38808158 | Diagnosis of factor XIII deficiency |
| Q45883486 | Efficacy of rituximab in acquired factor XIII inhibitor after arterial rFVIIa-induced thrombosis |
| Q35519432 | Life-threatening retro-pharyngeal bleed in a case of systemic lupus erythematosus--an uncommon but important evil of a common disease |
| Q36906072 | New developments in the management of congenital Factor XIII deficiency |
| Q34924736 | Tocilizumab induced acquired factor XIII deficiency in patients with rheumatoid arthritis |
| Q47698980 | Treatment of an acquired Factor XIII inhibitor in an adolescent with systemic lupus erythematosus and renal failure |
Search more.